Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Di Marzo

Showing results (11-20 of 1,157) with videos related to

Pageof 116
Sort By:
Drug Discovery Today|October 1, 2008
CB(1) receptor antagonism: biological basis for metabolic effectsVincenzo Di Marzo
Reviews of Physiology, Biochemistry and Pharmacology|May 16, 2008
Endocannabinoids: synthesis and degradationV Di Marzo
Biochemistry. Biokhimiia|April 4, 1998
2-Arachidonoyl-glycerol as an "endocannabinoid": limelight for a formerly neglected metaboliteV Di Marzo
Pharmacological Research|June 30, 2009
The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitationVincenzo Di Marzo
Nature Reviews. Drug Discovery|August 31, 2018
Corrigendum: New approaches and challenges to targeting the endocannabinoid systemVincenzo Di Marzo
Nature Reviews. Drug Discovery|August 18, 2018
New approaches and challenges to targeting the endocannabinoid systemVincenzo Di Marzo
Annals of the New York Academy of Sciences|January 10, 2006
Effects of melatonin in perimenopausal and menopausal women: our personal experienceG Bellipanni, F DI Marzo, F Blasi, et al.
British Journal of Pharmacology|August 20, 2016
The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulationsStefania Petrosino, Vincenzo Di Marzo
Lipids in Health and Disease|January 14, 2022
(Wh)olistic (E)ndocannabinoidome-Microbiome-Axis Modulation through (N)utrition (WHEN) to Curb Obesity and Related DisordersJyoti Sihag, Vincenzo Di Marzo
Current Pharmaceutical Design|September 11, 2008
The role of the endocannabinoid system in Alzheimer's disease: facts and hypothesesTiziana Bisogno, Vincenzo Di Marzo
Pageof 116

Showing results (11-20 of 1,157) with videos related to

Sort By:
Pageof 116
Drug Discovery Today|October 1, 2008
CB(1) receptor antagonism: biological basis for metabolic effectsVincenzo Di Marzo
Reviews of Physiology, Biochemistry and Pharmacology|May 16, 2008
Endocannabinoids: synthesis and degradationV Di Marzo
Biochemistry. Biokhimiia|April 4, 1998
2-Arachidonoyl-glycerol as an "endocannabinoid": limelight for a formerly neglected metaboliteV Di Marzo
Pharmacological Research|June 30, 2009
The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitationVincenzo Di Marzo
Nature Reviews. Drug Discovery|August 31, 2018
Corrigendum: New approaches and challenges to targeting the endocannabinoid systemVincenzo Di Marzo
Nature Reviews. Drug Discovery|August 18, 2018
New approaches and challenges to targeting the endocannabinoid systemVincenzo Di Marzo
Annals of the New York Academy of Sciences|January 10, 2006
Effects of melatonin in perimenopausal and menopausal women: our personal experienceG Bellipanni, F DI Marzo, F Blasi, et al.
British Journal of Pharmacology|August 20, 2016
The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulationsStefania Petrosino, Vincenzo Di Marzo
Lipids in Health and Disease|January 14, 2022
(Wh)olistic (E)ndocannabinoidome-Microbiome-Axis Modulation through (N)utrition (WHEN) to Curb Obesity and Related DisordersJyoti Sihag, Vincenzo Di Marzo
Current Pharmaceutical Design|September 11, 2008
The role of the endocannabinoid system in Alzheimer's disease: facts and hypothesesTiziana Bisogno, Vincenzo Di Marzo
Pageof 116